Galectin Therapeutics (GALT) Return on Equity [ROE] (2011 - 2021)
Galectin Therapeutics' Return on Equity [ROE] was -728.50% in Q4 2021, down 638.74 percentage points from -89.75% a year earlier and down 459.54 percentage points from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Return on Equity [ROE] (2011 - 2021) Analysis & Trends
For FY2021, Return on Equity [ROE] at Galectin Therapeutics came in at -262.51%, down 191.77 percentage points from FY2020.
- Return on Equity [ROE] shows a five-year change of -111.19 percentage points (FY2016 to FY2021).
- In earlier years, Return on Equity [ROE] was -70.74% in FY2020 (-16.53 pp), -54.21% in FY2019 (+544.28 pp), -598.49% in FY2018 (-265.88 pp) and -332.62% in FY2017 (-181.30 pp).
- The Q4 2021 figure marks the lowest quarterly Return on Equity [ROE] since Q1 2018.
- Compared with a year earlier, Return on Equity [ROE] has declined for seven straight quarters, with an average year-over-year change of -123.02 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2019 (a gain of 7636.90 percentage points); the worst was Q1 2018 (a drop of 7655.34 percentage points).
- Per Business Quant data, GALT's Return on Equity [ROE] in the three quarters before Q4 2021 was -268.96% (Q3 2021), -178.10% (Q2 2021) and -134.67% (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -728.50% |
| Sep 30, 2021 | -268.96% |
| Jun 30, 2021 | -178.10% |
| Mar 31, 2021 | -134.67% |
| Dec 31, 2020 | -89.75% |
| Sep 30, 2020 | -63.74% |
| Jun 30, 2020 | -46.10% |
| Mar 31, 2020 | -34.10% |
| Dec 31, 2019 | -29.02% |
| Sep 30, 2019 | -22.95% |
| Jun 30, 2019 | -40.62% |
| Mar 31, 2019 | -233.48% |
| Dec 31, 2018 | -223.83% |
| Sep 30, 2018 | -172.84% |
| Jun 30, 2018 | -331.42% |
| Mar 31, 2018 | -7,870.38% |
| Dec 31, 2017 | -7,780.82% |
| Sep 30, 2017 | -731.76% |
| Jun 30, 2017 | -309.21% |
| Mar 31, 2017 | -215.04% |
API Access
Galectin Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();